Migraine Trial, Recruiting NCT07454798 Sponsor: Children's Mercy Hospital Kansas City Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT07454798
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 10 and 16 years old (inclusive)
  • You have been diagnosed with migraine (with or without aura, or chronic migraine) by a headache specialist
  • You get at least 4 migraine headaches per month
  • You have periods between migraines where you are headache-free

Who may not be able to join:

  • You have a significant physical, mental health, or developmental condition that might make it hard to take part in the study activities
  • You have a high score on a balance and dizziness symptom questionnaire, or you have new or worsening balance/dizziness symptoms before the study begins (confirm with trial site)
  • You have started a new medication to prevent migraines within the last 4 weeks before joining the study
  • You are currently receiving a talking therapy or mind-body treatment for migraines, such as cognitive behavioural therapy or biofeedback
  • You have a history of epilepsy or seizures triggered by flashing lights

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mark A Connelly, PhD, Children's Mercy

Phone: 816-234-3193

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Mercy Hospital Kansas City
Registry
ClinicalTrials.gov
Start date
13 May 2026
Est. completion
31 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Recruitment and Enrollment; Feasibility of Randomization and Treatment Initiation; Treatment Credibility (Child-Adapted Credibility/Expectancy Questionnaire - Credibility Subscale); Percent of Prescribed Virtual Reality Sessions Completed; Mean Duration of Virtual Reality Sessions; Cybersickness Symptoms Questionnaire (CSQ-VR) Mean Total Score; Child-Adapted System Usability Scale (SUS) Total Score; Retention Through 3-Month Follow-Up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov